Sciety
Fund of fundsStockholm · Seed–Growth · 21 people tracked
Investment thesis
Sciety targets Nordic and European life science and digital health companies with market leadership potential. The firm invests across the sector, from precision diagnostics and genomics to biopharma development and digital healthcare solutions. Focus areas include innovative medical technology addressing aging populations, lifestyle diseases, and healthcare process optimization. The platform leverages a network of venture capital and corporate venture capital partners for co-investment, emphasizing active ownership and long-term value creation through introductions, strategic partnerships, and board support.
Source: firm website, verified Jul 21, 2026.
Team · 21 people
from the firm's websiteCo-founder and managing partner of Sciety with expertise in life sciences and healthcare investments.
Investments · 13 tracked
founders shown can be your intro pathDeveloped a new type of targeted radioimmunotherapy with first-in-class potential showing 100% survival rate in animal studies.
Provides proprietary software solutions that help hospitals implement best practice throughout the entire care chain from diagnosis to rehabilitation.
Develops an innovative bone substitute for spinal surgery to improve bone healing in spinal fusion procedures.
Provides groundbreaking technology and instruments for large-scale production of precision drugs including peptides and oligonucleotides.
Clinical-stage pharmaceutical company developing a first-in-class treatment for neuropathic pain with blockbuster potential in adjacent indications.
Frequently asked questions
- What stage does Sciety invest at?
- Sciety invests at the Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Sciety focus on?
- Sciety focuses on Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Sciety located?
- Sciety is headquartered in Stockholm, SE.
- Does Sciety lead rounds?
- Yes, Sciety leads investment rounds.
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.